- Home
- TFFP
as 11-15-2024 3:40pm EST
TFF Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. It is focused on the development of inhaled dry powder drugs for the treatment of lung disorders.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | AUSTIN |
| Market Cap: | 6.9M | IPO Year: | 2019 |
| Target Price: | $44.00 | AVG Volume (30 days): | 682.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -7.51 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.27 - $11.00 | Next Earning Date: | 11-26-2024 |
| Revenue: | $1,202,586 | Revenue Growth: | 53.17% |
| Revenue Growth (this year): | 60.25% | Revenue Growth (next year): | -30.61% |
Latest TFF Pharmaceuticals Inc. News
TFFP Breaking Stock News: Dive into TFFP Ticker-Specific Updates for Smart Investing
MT Newswires
3 days ago
Top Midday Decliners
MT Newswires
3 days ago
Sector Update: Health Care Stocks Decline Premarket Friday
MT Newswires
3 days ago
TFF Pharmaceuticals Shares Slump After Board Approves Dissolution
MT Newswires
3 days ago
Top Premarket Decliners
GlobeNewswire
3 days ago
TFF Pharmaceuticals Announces It Will Wind Down Operations
Zacks
a month ago
TFF Pharmaceuticals (TFFP) Upgraded to Strong Buy: Here's Why
MT Newswires
2 months ago
Top Premarket Decliners
GlobeNewswire
2 months ago
TFF Pharmaceuticals’ Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug Delivery
Compare TFFP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TFFP TFF Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.